Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Summary

Introduction

Dr. Ulrich Bishop hosts this medical podcast discussing cholesterol management and cardiovascular health across diverse patient populations. In this episode, Dr. Bishop covers several specialized topics including ketogenic diets, cholesterol management in women, and treatment considerations for older patients, those with chronic renal disease, and transplant recipients. The discussion focuses on practical clinical decision-making for patient groups that often fall outside standard treatment guidelines.

Key Takeaways:

• Ketogenic and very low-carbohydrate diets can effectively flatten blood sugar levels, reduce appetite, lower blood pressure, improve insulin control, and support weight loss, leading to better overall patient wellbeing.

• A major concern with ketogenic diets is that they often replace carbohydrates with saturated fats, which significantly raises LDL cholesterol levels, particularly in "hyper responders," potentially offsetting cardiovascular benefits.

• High LDL particle numbers and elevated LDL cholesterol remain linked to arterial plaque buildup even when particles are large and fluffy, as evidenced by young patients with familial hypercholesterolemia who develop arterial disease.

• For patients on ketogenic diets with high cardiovascular risk, Dr. Bishop recommends maintaining reduced carbohydrate intake while minimizing saturated fat and pursuing the lowest possible LDL cholesterol targets, pending results from ongoing research trials.

• Women clearly benefit from statin therapy and non-statin cholesterol-lowering medications for reducing all-cause and cardiovascular mortality, contrary to historical uncertainty.

• Hormone replacement therapy is considered potentially beneficial for perimenopausal women without clear evidence of increased cardiovascular disease risk, supporting mood and bone health.

• Cholesterol-lowering medications should be avoided during pregnancy due to lack of safety data, requiring careful planning when young women with familial hypercholesterolemia consider conception.

• Treatment decisions for older patients should involve individualized risk assessment conversations, particularly in primary prevention settings, rather than automatic age-based cutoffs.

• Patients with chronic renal disease on dialysis carry very high cardiovascular risk, though statin data is unclear for this population; however, pre-transplant patients warrant cholesterol lowering to protect their vasculature for their upcoming transplant.

• Transplant recipients across all organ types often require LDL cholesterol lowering therapy, with specialist input needed regarding potential drug interactions between transplant medications and statins.